Works by MASATAKA SAWAKI


Results: 82
    1
    2
    3

    Amyloid tumor of the breast.

    Published in:
    Surgical Case Reports, 2019, v. 5, n. 1, p. 1, doi. 10.1186/s40792-019-0591-z
    By:
    • Mori, Makiko;
    • Kotani, Haruru;
    • Sawaki, Masataka;
    • Hattori, Masaya;
    • Yoshimura, Akiyo;
    • Gondo, Naomi;
    • Adachi, Yayoi;
    • Kataoka, Ayumi;
    • Sugino, Kayoko;
    • Horisawa, Nanae;
    • Terada, Mitsuo;
    • Ozaki, Yuri;
    • Iwata, Hiroji
    Publication type:
    Article
    4
    5
    6
    7
    8

    Management of breast cancer in older patients.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 7, p. 674, doi. 10.1093/jjco/hyac054
    By:
    • Sawaki, Masataka;
    • Shimomura, Akihiko;
    • Shien, Tadahiko;
    • Iwata, Hiroji
    Publication type:
    Article
    9
    10

    Corrigendum to: A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study).

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 9, p. 1479, doi. 10.1093/jjco/hyab124
    By:
    • Shimomura, Akihiko;
    • Tamura, Kenji;
    • Tanaka, Kiyo;
    • Mizutani, Tomonori;
    • Sasaki, Keita;
    • Sekino, Yuta;
    • Sawaki, Masataka;
    • Shien, Tadahiko;
    • Shibata, Taro;
    • Iwata, Hiroji
    Publication type:
    Article
    11

    A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study).

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 9, p. 1471, doi. 10.1093/jjco/hyab101
    By:
    • Shimomura, Akihiko;
    • Tamura, Kenji;
    • Tanaka, Kiyo;
    • Mizutani, Tomonori;
    • Sasaki, Keita;
    • Sekino, Yuta;
    • Sawaki, Masataka;
    • Shien, Tadahiko;
    • Shibata, Taro;
    • Iwata, Hiroji
    Publication type:
    Article
    12
    13

    Impact of BMI for clinical outcomes in Japanese breast cancer patients.

    Published in:
    Japanese Journal of Clinical Oncology, 2020, v. 50, n. 3, p. 230, doi. 10.1093/jjco/hyz175
    By:
    • Gondo, Naomi;
    • Sawaki, Masataka;
    • Hattori, Masaya;
    • Yoshimura, Akiyo;
    • Kotani, Haruru;
    • Adachi, Yayoi;
    • Kataoka, Ayumi;
    • Sugino, Kayoko;
    • Mori, Makiko;
    • Horisawa, Nanae;
    • Terada, Mitsuo;
    • Ozaki, Yuri;
    • Iwata, Hiroji
    Publication type:
    Article
    14
    15
    16
    17
    18

    Feasibility study of contralateral risk-reducing mastectomy with breast reconstruction for breast cancer patients with BRCA mutations in Japan.

    Published in:
    Breast Cancer (13406868), 2018, v. 25, n. 5, p. 539, doi. 10.1007/s12282-018-0850-z
    By:
    • Yoshimura, Akiyo;
    • Okumura, Seiko;
    • Sawaki, Masataka;
    • Hattori, Masaya;
    • Ishiguro, Junko;
    • Adachi, Yayoi;
    • Kotani, Haruru;
    • Gondo, Naomi;
    • Kataoka, Ayumi;
    • Iwase, Madoka;
    • Onishi, Sakura;
    • Sugino, Kayoko;
    • Terada, Mitsuo;
    • Horisawa, Nanae;
    • Mori, Makiko;
    • Takaiso, Nobue;
    • Hyodo, Ikuo;
    • Iwata, Hiroji
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Nodular fasciitis of the breast.

    Published in:
    Breast Cancer (13406868), 2007, v. 14, n. 3, p. 337, doi. 10.2325/jbcs.14.337
    By:
    • Hayashi, Hironori;
    • Nishikawa, Mikiko;
    • Watanabe, Reiko;
    • Sawaki, Masataka;
    • Kobayashi, Hironobu;
    • Shibata, Arihiro;
    • Kikumori, Toyone;
    • Nagasaka, Tetsuro;
    • Imai, Tsuneo
    Publication type:
    Article
    30
    31
    32
    33
    34
    35

    The overall survival of breast cancer patients without adjuvant therapy.

    Published in:
    Surgery Today, 2019, v. 49, n. 7, p. 610, doi. 10.1007/s00595-019-01775-z
    By:
    • Onishi, Sakura;
    • Sawaki, Masataka;
    • Ishiguro, Junko;
    • Kataoka, Ayumi;
    • Iwase, Madoka;
    • Sugino, Kayoko;
    • Adachi, Yayoi;
    • Gondo, Naomi;
    • Kotani, Haruru;
    • Yoshimura, Akiyo;
    • Hattori, Masaya;
    • Matsuo, Keitaro;
    • Yatabe, Yasushi;
    • Iwata, Hiroji
    Publication type:
    Article
    36
    37
    38

    Cost-Effectiveness of Trastuzumab With or Without Chemotherapy as Adjuvant Therapy in HER2-Positive Elderly Breast Cancer Patients: A Randomized, Open-Label Clinical Trial, the RESPECT Trial.

    Published in:
    Clinical Drug Investigation, 2022, v. 42, n. 3, p. 253, doi. 10.1007/s40261-022-01124-y
    By:
    • Takumoto, Yuki;
    • Shiroiwa, Takeru;
    • Shimozuma, Kojiro;
    • Iwata, Hiroji;
    • Takahashi, Masato;
    • Baba, Shinichi;
    • Kobayashi, Kokoro;
    • Hagiwara, Yasuhiro;
    • Kawahara, Takuya;
    • Uemura, Yukari;
    • Mukai, Hirofumi;
    • Taira, Naruto;
    • Sawaki, Masataka
    Publication type:
    Article
    39
    40
    41
    42
    43

    Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study

    Published in:
    Breast Cancer: Basic & Clinical Research, 2018, n. 12, p. 1, doi. 10.1177/1178223418786243
    By:
    • Yamashiro, Hiroyasu;
    • Sawaki, Masataka;
    • Masuda, Norikazu;
    • Okumura, Yasuhiro;
    • Takano, Toshimi;
    • Tokunaga, Eriko;
    • Saito, Tsuyoshi;
    • Sagara, Yasuaki;
    • Yamazaki, Kosuke;
    • Kawaguchi, Yoshihiro;
    • Lee, Tecchuu;
    • Ozaki, Shinji;
    • Yamagami, Kazuhiko;
    • Yamamoto, Naohito;
    • Kuroi, Katsumasa;
    • Suwa, Hirofumi;
    • Ohtani, Shoichiro;
    • Ito, Toshikazu;
    • Yasuno, Shinji;
    • Morita, Satoshi
    Publication type:
    Article
    44
    45
    46

    The Absence of Cancer in the Location of a Breast Tissue Marker After Neoadjuvant Chemotherapy may Predict Pathological Complete Response with High Accuracy: Results from a Phase II Trial.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 6, p. 3224, doi. 10.1245/s10434-023-13199-8
    By:
    • Kataoka, Ayumi;
    • Sawaki, Masataka;
    • Horisawa, Nanae;
    • Kotani, Haruru;
    • Yoshimura, Akiyo;
    • Hattori, Masaya;
    • Adachi, Yayoi;
    • Sugino, Kayoko;
    • Endo, Yuka;
    • Ozaki, Yuri;
    • Sasaki, Eiichi;
    • Hosoda, Waki;
    • Iwata, Hiroji
    Publication type:
    Article
    47
    48
    49
    50

    Prediction of pathological margin status using preoperative contrast‐enhanced MRI in patients with early breast cancer who underwent skin‐sparing mastectomy.

    Published in:
    Breast Journal, 2019, v. 25, n. 2, p. 202, doi. 10.1111/tbj.13194
    By:
    • Kataoka, Ayumi;
    • Sawaki, Masataka;
    • Onishi, Sakura;
    • Iwase, Madoka;
    • Sugino, Kayoko;
    • Ishiguro, Junko;
    • Gondo, Naomi;
    • Kotani, Haruru;
    • Yoshimura, Akiyo;
    • Hattori, Masaya;
    • Iwata, Hiroji;
    • Okumura, Seiko;
    • Sasaki, Eiichi;
    • Yatabe, Yasushi;
    • Yoshimura, Kenichi;
    • Omi, Kumiko
    Publication type:
    Article